No Benefit of Rivaroxaban in COVID Outpatients: PREVENT-HD ...Middle East

PREVENT-HD is the largest randomized study to look at anticoagulation in nonhospitalized COVID-19 patients and joins a long list of smaller trials also showing no benefit with this approach. Medscape Medical News

Hence then, the article about no benefit of rivaroxaban in covid outpatients prevent hd was published today ( Thursday 10/11/2022 - 11:33 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( No Benefit of Rivaroxaban in COVID Outpatients: PREVENT-HD )

Also on site :

• General manager position restricted to only Saudis; Qiwa clarifies
• Why is ‘Deuce Bigalow’ rooting for Viktor Orban in Hungary?
• Lady Gaga Pauses Tokyo Concert to Condemn ICE and Support Americans ‘Who Are Being Mercilessly Targeted’: ‘We Need to Get Back to a Place of Safety’